Related Experiment Videos
Drug interactions with antiviral drugs
1Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Clinical Pharmacokinetics
|May 1, 1996
Summary
Antiviral drug interactions are critical in immunocompromised patients. Careful consideration of drug combinations, like zidovudine with ganciclovir, is essential to prevent adverse events and ensure patient safety.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Antiviral drug interactions pose significant challenges, particularly in immunocompromised patients on multiple medications.
- Understanding these interactions is crucial for optimizing treatment efficacy and minimizing adverse events.
Purpose of the Study:
- To review and summarize known drug-drug interactions involving common antiviral medications.
- To highlight potential pharmacokinetic and pharmacodynamic interactions relevant to clinical practice.
Main Methods:
- Literature review of studies investigating antiviral drug interactions.
- Analysis of pharmacokinetic data and clinical trial outcomes related to drug combinations.
- Identification of specific drug pairs with documented interactions or contraindications.
Main Results:
- Zidovudine generally shows good tolerability with other antiretrovirals but coadministration with ganciclovir should be avoided due to hematological intolerance.
- Didanosine absorption can be affected by antacids and its concentration increased by ganciclovir.
- Potential interactions exist with drugs affecting gastric pH or undergoing cytochrome P450 metabolism.
Conclusions:
- Antiviral drug interactions require careful management, especially in immunocompromised patients.
- Clinical benefits and safety profiles of individual drugs must be weighed against potential interaction risks.
- Further research is needed to fully elucidate the clinical consequences of many documented antiviral drug interactions.